Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
06/2003
06/24/2003US6583290 14-methyl epothilone derivatives
06/24/2003US6583172 Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
06/24/2003CA2100861C Ion-sensitive dyes
06/19/2003WO2003049746A2 Combination of cytochome p450 dependent protease inhibitors
06/19/2003WO2003049734A1 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
06/19/2003US20030114666 Antibacterial agents
06/19/2003US20030114635 Synthesis of anhydroglycitol esters of improved colour
06/19/2003US20030114558 Useful as nucleating agents and especially useful for improving optical properties of polymeric materials
06/19/2003US20030114541 Gels comprising asymmetric dipolar multi-substituted alditol derivatives
06/19/2003US20030114485 Killing drug resistant cancer cells; controlling cell differentiation
06/19/2003US20030114477 Rapamycin 29-Enols
06/19/2003CA2468994A1 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
06/18/2003EP1319662A1 Process for preparation of 7-oxabicyclo 2.2.1]hept-5-ene-2-carboxylic acid derivatives
06/18/2003EP1319011A1 Triazolo-epothilones
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1021414B1 Frangible compounds for pathogen inactivation
06/18/2003CN1424315A Ginkgo lactone compound and its preparation and medicinal composition containing it
06/18/2003CN1111536C Preparation of Milbe 13 derivative and its intermediate
06/18/2003CN1111527C Sesquilterpenic internal ester compound for antiulcer of alimentary tract
06/17/2003US6580003 Catalytic asymmetric desymmetrization of meso compounds
06/17/2003US6579882 Cell adhesion-inhibiting antiinflammatory compounds
06/12/2003WO2003048168A2 Trioxane derivatives as antimalaria or anticancer compounds
06/12/2003WO2003048167A1 Trioxane derivatives
06/12/2003WO2003048166A1 Podophyllotoxins as antiproliferative agents
06/12/2003WO2003048156A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine
06/12/2003US20030109610 Diacetal composition, polyolefin nucleating agent comprising the diacetal composition, polyolefin resin compositions containing the diacetal composition, method for manufacturing the resin composition, and moldings
06/12/2003US20030109571 Thromboxane ligands without blood clotting side effects
06/12/2003US20030109546 Treatment of psychotic disorders comprising co-therapy with anticonvulsant derivatives and atypical antipsychotics
06/12/2003US20030106463 Use to provide transparent perylene pigments having excellent application and color properties; mixture with the pigment and rosin
06/12/2003CA2469224A1 Trioxane derivatives
06/12/2003CA2469223A1 Trioxane derivatives as antimalaria or anticancer compounds
06/11/2003EP1317460A1 Compounds containing oxazolidinone moiety and uses thereof
06/11/2003EP1317458A2 Interphenylene 7-oxabicyclic[2.2.1]heptane oxazoles as prostaglandin f2alpha antagonists
06/11/2003EP1317457A2 INTERHETEROARYL 7-OXABICYCLIC 2.2.1]HEPTANE OXAZOLES AS PROSTAGLANDIN F 2$g(a)? ANTAGONISTS
06/11/2003EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317451A1 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317445A2 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003CN1111162C Artemisinin derivatives, method for preparation thereof and pharmaceutical compositions containing the same
06/11/2003CN1111161C Diacetal composition, process for preparation of same, nucleating agent for polyolefins containing same, polyolefin resin compositions, and moldings
06/10/2003US6576773 Method for production of pyromellitic dianhydride
06/10/2003US6576651 Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones
06/05/2003WO2003045957A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
06/05/2003WO2003045953A1 Crystals of taxane derivative and process for their production
06/05/2003WO2003045933A2 Preparation and use of gamma-butyrolactones as cross-linking agents
06/05/2003WO2003045919A2 Process for the synthesis of amine ethers from secondary amino oxides and uses
06/05/2003WO2003045324A2 14-methyl-epothilones
06/05/2003US20030105339 Psoralen compounds with aminoalkyl groups on the 5' position and optional alkyl groups on positions 4,4' and 8 that bind to nucleic acid of pathogens, and under photoactivation crosslink the nucleic acid, inactivating the pathogen
06/05/2003US20030105330 Synthesis of epothilones, intermediates thereto and analogues thereof
06/05/2003US20030105125 Tropane analogs and methods for inhibition of monoamine transport
06/05/2003US20030105096 Serotonin transport inhibitors
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105064 Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2alpha antagonists
06/05/2003CA2468623A1 Preparation and use of gamma-butyrolactones as cross-linking agents
06/05/2003CA2468422A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
06/05/2003CA2464107A1 Process for the synthesis of amine ethers from secondary amino oxides and uses
06/04/2003EP1315732A2 Radicicol and monocillin and their analogues and uses thereof
06/04/2003EP1315719A1 Multivalent neuraminidase inhibitor conjugates
06/04/2003EP1075476B1 Novel benzimidazoles and benzoxazoles
06/04/2003EP1007031B1 4-cyano-4-deformylsordarin derivatives
06/04/2003EP0873342B1 1,7-diaroxy- or 1,7-diarylthio-substituted perylene-3,4,9,10-tetracarboxylic acids and their dianhydrides and diimides
06/04/2003CN1421437A Bridged peryleneone/quinolindeone
06/04/2003CN1110500C Carbamoyl substituted acetals and compositions with the same as component
06/04/2003CN1110491C Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
06/03/2003US6573296 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
05/2003
05/30/2003WO2003044022A2 Photochromic naphthopyran for ophthalmic articles
05/30/2003WO2003044006A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
05/30/2003WO2003043959A1 Method for preparing a composition containing at least an internal dehydrating product of a hydrogenated sugar
05/29/2003US20030100773 Producing ciguatoxin via cross-coupling reaction of alkylborane and cyclic ketene acetal phosphate in presence of palladium ((1,1'-bis(diphenylphosphino)ferrocene)chloride as catalyst
05/29/2003US20030100577 Neurotrophic agents in treatment of solid tumors and vascular disease
05/28/2003EP1314754A1 Bridged Perinones/Quinophtalones
05/28/2003EP1314730A1 Reagent for determining singlet oxygen
05/28/2003EP1313741A2 Fluorinated and alkylated alditol derivatives and polyolefin articles containing same
05/28/2003EP1313690A1 Method of producing fluorinated and chlorinated benzaldehydes and compositions thereof
05/28/2003CN1420382A Liquid crystal display contg. chiral dopant
05/28/2003CN1109687C Macrolides with antitumor activity, method for preparing same and use thereof
05/27/2003US6569900 Fulvic acid and its use in the treatment of various conditions
05/27/2003US6569893 Amino acid derivatives of triptolide compounds as immune modulators and anticancer agents
05/27/2003US6569892 Useful as agent for measurement of nitrogen monoxide, also for measuring intracellular nitrogen monoxide concentration of an individual
05/27/2003US6569891 Antihypertensive compound from Caesalpinia brasiliensis
05/27/2003US6569355 Chiral compounds, and their use as chiral dopants for the preparation of cholesteric liquid-crystalline compositions
05/27/2003CA2412553A1 Bridged perinones/quinophthalones
05/22/2003WO2003042699A1 Tagged microparticle compositions and methods
05/22/2003WO2003042217A2 Method for making epothilone compounds by bioconversion with microorganisms
05/22/2003WO2003042203A1 Chromene compound
05/22/2003WO2003041643A2 Hsp90-inhibiting zearalanol compounds and methods of producing and using same
05/22/2003US20030097028 Distilling a medium containing internal dehydration product to obtain a distillate enriched with this product, purifying; contacting with stabilizing agent; shaping the resulting internal dehydration product of a hydrogenated sugar
05/22/2003US20030096806 For use as pesicides, herbicides; crop protection
05/22/2003US20030096381 Production of polyketides
05/22/2003US20030096117 Base structure is a chromene(3,2-a)fluorene ring containing spiro-fused rings; photochromic lenses; large fading rate, less color when deteriorated, and excellent light resistance in the photochromic properties
05/21/2003EP1312374A1 Sugar absorption inhibitors and process for producing the same
05/21/2003EP1311291A2 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists
05/21/2003EP0792148B1 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
05/21/2003CN1418881A Novel method for synthesizing Eposilonqun of natural products
05/21/2003CN1109035C 12 position aryl-substituted arteannuin derivant preparation process and application thereof
1 ... 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 ... 174